CoChat

Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma

Gordon, GJ, Mani, M, Mukhopadhyay, L, Dong, L, Yeap, BY, Sugarbaker, DJ, Bueno, R · 2007 · The Journal of Pathology
Cited by 68

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Inhibitor of apoptosis proteins (IAPs) are overexpressed by most neoplasms and promote tumour cell survival after a wide variety of apoptotic stimuli elicited via intrinsic (ie mitochondrial) and extrinsic (ie death receptor) pathways. It has previously been reported that one of these proteins, IAP‐1(MIHC/cIAP2), is overexpressed in malignant pleural mesothelioma (MPM) and is responsible for a large degree of the resistance of cultured MPM cells to cisplatin. Subsequent analysis in a larger number of human tumours revealed that additional IAPs (eg IAP‐2/MIHB/cIAP1, livin/ML‐IAP/KIAP, survivin, and XIAP/MIHA/hILP) are also overexpressed in MPM and, with the exception of IAP‐2, have expression patterns that correlate with prognosis. In the present study, potential regulatory mechanisms of IAP genes in MPM were investigated and it was found that tumour necrosis factor‐alpha (TNF‐α) can increase mRNA and protein levels of IAP‐1, IAP‐2, and XIAP, but not livin or survivin in MPM cell lines (n = 4). It was also found that IAP gene expression levels are increased concomitantly with translocation to the nucleus of the TNF‐responsive transcription factor NF‐κB. Co‐incubation of MPM cells with TNF‐α and pyrrolidine dithiocarbamate (PDTC), an NF‐κB inhibitor, prevented TNF‐mediated up‐regulation of IAP gene expression levels. In survival studies, TNF‐α was not toxic to MPM cells at any concentration examined. However, MPM cells exposed to TNF‐α were twice as resistant to cisplatin in dose response survival assays compared with unstimulated controls and were found to have a significantly greater fraction of surviving cells at multiple cisplatin concentrations (p < 0.0087). Finally, it was found that levels of circulating TNF‐α were statistically significantly (p = 0.031) (median 312.5 pg/ml) higher in MPM patients (n = 6) prior to surgical tumour debulking compared with those after surgery (median 0 pg/ml). These results when combined with previous observations by our laboratory and others strongly suggest that IAPs act synergistically with TNF family members to promote survival of MPM tumour cells after exposure to cisplatin and possibly other chemotherapeutic drugs. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.2120

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 68

Metadata

Authors
Gordon, G., Mani, M., Mukhopadhyay, L., Dong, L., Yeap, B., Sugarbaker, D., & Bueno, R.
Venue
The Journal of Pathology
Publisher
Wiley
Published
2007-01-25
Volume
211
Issue
4
Pages
439-446
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W2012095464
Cited by
68
References
5
FWCI
2.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.